From: Recombinant proteins in therapeutics: haemophilia treatment as an example
Protein | Clinical utility |
---|---|
Coagulant factors | Haemophilia A and B |
DNase I | Cystic fibrosis |
Erythropoietin | Anaemia in chronic renal disease |
Glucocerebrosidase | Gaucher disease |
Growth hormone | Nanism hypophyseal |
Insulin | Diabetes |
Alpha interferon | Some leukaemias, Kaposi's sarcoma, hepatitis B and C |
Gamma-1b interferon | Chronic granulomatous disease |
Interleukin-2, -3 and -4 | Immunotherapy of cancer |
Tissue-type plasminogen activator | Acute myocardial infarction, massive pulmonary embolism |
Antibodies for cellular immunotherapy | Neoplasic processes |
Vaccines | Influenza, hepatitis A and B |
Monoclonal antibodies anti-antibodies | Lupus, rheumatoid arthritis |